EAM
RCKT icon

Erste Asset Management’s Rocket Pharmaceuticals RCKT Stock Holding History

Erste Asset Management’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-44,700
Closed -$147K – 652
2025
Q3 		$147K Hold
44,700
– – ﹤0.01% 569
2025
Q2 		$113K Hold
44,700
– – ﹤0.01% 817
2025
Q1 		$339K Hold
44,700
– – ﹤0.01% 452
2024
Q4 		$525K Hold
44,700
– – 0.01% 437
2024
Q3 		$825K Hold
44,700
– – 0.01% 395
2024
Q2 		$958K Hold
44,700
– – 0.01% 376
2024
Q1 		$1.22M Buy
44,700
+28,000
+168% +$795K 0.02% 354
2023
Q4 		$516K Hold
16,700
– – 0.01% 420
2023
Q3 		$346K Hold
16,700
– – 0.01% 446
2023
Q2 		$335K Hold
16,700
– – 0.01% 457
2023
Q1 		$272K Hold
16,700
– – 0.01% 476
2022
Q4 		$326K Hold
16,700
– – 0.01% 454
2022
Q3 		$234K Hold
16,700
– – 0.01% 486
2022
Q2 		$218K Hold
16,700
– – ﹤0.01% 507
2022
Q1 		$266K Hold
16,700
– – 0.01% 491
2021
Q4 		$379K Hold
16,700
– – 0.01% 446
2021
Q3 		$500K Hold
16,700
– – 0.01% 409
2021
Q2 		$724K Hold
16,700
– – 0.01% 375
2021
Q1 		$724K Hold
16,700
– – 0.02% 355
2020
Q4 		$933K Buy
+16,700
New +$609K 0.03% 344

Other funds holding RCKT

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $1.26B AUM 60.23% 1-Year Est. Return
NM
Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

Erste Asset Management's RCKT Position: Q4 2025 in Review

Erste Asset Management sold out of Rocket Pharmaceuticals (RCKT) in Q4 2025, closing a stake of 44,700 shares — an estimated $147K sold.

Erste Asset Management first reported a position in RCKT in Q4 2020 and held it in 20 quarters. The position peaked at $1.22M in Q1 2024. 186 funds tracked by Wall St. Rank hold RCKT as of Q4 2025.

  • Erste Asset Management reported no remaining Rocket Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Erste Asset Management sold 44,700 Rocket Pharmaceuticals shares in Q4 2025, an estimated $147K.
  • Erste Asset Management first reported a position in Rocket Pharmaceuticals in Q4 2020 and held it in 20 quarters.
  • Erste Asset Management's Rocket Pharmaceuticals position peaked at $1.22M in Q1 2024.
  • 186 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q4 2025.

Based on Erste Asset Management's 13F filing for Q4 2025, filed 11 Feb 2026.